People who used a wellness app or a medically tailored meal plan after quitting regained 3% of lost weight, versus 10% for those who used neither.
Recap by typeshit. Full story at WDBJ7.
Lilly's pill had major heart events in 4.2% of patients vs 5.0% on insulin glargine. The Clinical Trial Vanguard argues rivals now need to show benefit, not just safety.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Researchers in Vienna reported nail detachment in 39% of GLP-1 users versus 9% of non-users. Authors say the self-reported data shows a link, not proof of cause.
The Emmy-nominated actress opens up on the Tamron Hall Show about her long skepticism of GLP-1 drugs and how her view changed.
Loading…